Charles River Laboratories | CRL - Interest Income

Stock Price
187.86
Daily Change
-13.76 -6.82%
Monthly
-13.07%
Yearly
12.98%
Q1 Forecast
204.00

Charles River Laboratories reported $1.1 in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Align Technology USD 3.25M 390K Sep/2025
Bio-Rad Laboratories USD 14.7M 21.5M Jun/2025
Bruker USD 2.9M 200K Jun/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Danaher USD 1.27 8M Sep/2025
Dentsply International USD 4M 1000K Mar/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Hologic USD 0.79 18.9M Dec/2025
Illumina USD 0.98 10M Sep/2025
Incyte USD 25.14M 2.21M Jun/2025
IQVIA Holdings USD 13M 3M Sep/2025
Merck EUR 17M 11M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Quest Diagnostics USD 2M 3M Jun/2025
Revvity USD 0.4 8.34M Sep/2025
Thermo Fisher Scientific USD 4.27 297M Sep/2025
United Therapeutics USD 51.3M 200K Jun/2025
Waters USD 2.5 4.51M Sep/2025
West Pharmaceutical Services USD 3.6M 500K Jun/2025